# A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy

> **NCT00106392** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 131 (actual)

## Conditions studied

- Erectile Dysfunction
- Prostate Cancer

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00106392
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2008-04
- **Final completion:** 2008-11
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2010-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00106392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00106392, "A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00106392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*